ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.160
-0.060 (-2.70%)
At close: Dec 16, 2025, 4:00 PM EST
2.170
+0.010 (0.46%)
After-hours: Dec 16, 2025, 6:21 PM EST
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $2.13 billion as of December 16, 2025. Its market cap has decreased by -40.13% in one year.
Market Cap
2.13B
Enterprise Value
2.73B
1-Year Change
-40.13%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $2.13B, a decrease of -85.65%. That is a compound annual growth rate of -33.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 2.19B | 16.98% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
| Mar 10, 2021 | 14.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 928.53B |
| Johnson & Johnson | 504.76B |
| AbbVie | 392.77B |
| UnitedHealth Group | 301.19B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 242.64B |
| Novo Nordisk | 221.32B |